Clinical Trials Browser

Standard of Care × Clear all

NCT05564390 2026-03-18

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Phase 2 Recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT05787834 2026-03-18

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer

Phase NA Recruiting

Breast Neoplasms

NCT07241585 2026-03-17

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

Phase NA Not yet recruiting

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT03486873 2026-03-16

MK-3475-587

Phase 3 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT00580515 2026-03-13

Trial of Family Focused Grief Therapy in Palliative Care and Bereavement

Phase NA Completed

Neoplasms

NCT01042379 2026-03-13

I-SPY

Phase 2 Recruiting

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT02540174 2026-03-13

ALTAKRA-1405

Phase NA Completed

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Tobacco Use

NCT04266886 2026-03-13

Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer

Phase NA Active not recruiting

Uterine Cervical Neoplasms

NCT05874297 2026-03-13

ONE

Phase NA Not yet recruiting

Anatomic Stage I Breast Cancer AJCC v8

NCT07023289 2026-03-13

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Phase 2 Recruiting

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT07176000 2026-03-13

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

Phase NA Not yet recruiting

Lung Neoplasms

NCT07302230 2026-03-13

EMPOWER

Phase NA Recruiting

Urinary Bladder Neoplasms

NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

NCT07155187 2026-03-11

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Phase 2/3 Recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04175678 2026-03-10

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

Phase NA Active not recruiting

Motor Activity, Obesity, Multiple Endocrine Neoplasia Type 1

NCT04565665 2026-03-10

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Phase 1/2 Recruiting

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT06122064 2026-03-10

A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04605458 2026-03-05

Contingency Management to Promote Smoking Abstinence in Cancer Patients

Phase NA Completed

Smoking Cessation

NCT06528990 2026-03-05

Telehealth Intervention for Ostomy Self-Management

Phase 2 Recruiting

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Colorectal Neoplasms

NCT07451197 2026-03-05

Family-Focused Study to Support Medication for Opioid Use Disorder

Phase NA Not yet recruiting

Lymphoma, Follicular, Opioid-Related Disorders

NCT05166694 2026-03-04

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

Phase NA Recruiting

Mental Disorders, Neoplasms

NCT05316701 2026-03-04

Orca-T

Phase 3 Active not recruiting

187 enrolled 15 charts

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07032701 2026-03-03

A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer

Phase NA Not yet recruiting

Skin Carcinoma

NCT04467021 2026-03-02

Cancer and Blood Pressure Management, CARISMA Study

Phase NA Active not recruiting

Carcinoma, Renal Cell, Cardiovascular Diseases, Carcinoma, Medullary, Renal Insufficiency, Chronic

NCT05681039 2026-03-02

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT06040762 2026-03-02

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

Phase NA Recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06295367 2026-03-02

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Phase NA Recruiting

Other solid neoplasm

Malignant Solid Neoplasm

NCT06502691 2026-03-02

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms

NCT07206056 2026-03-02

TulmiSTAR-01

Phase 1/2 Recruiting

Progressive Metastatic Castrate Resistant Prostate Cancer

NCT02645149 2026-02-27

Match Mel

Phase 2 Completed

Melanoma

NCT03067181 2026-02-27

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Phase 3 Recruiting

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT03808337 2026-02-27

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Phase 2 Recruiting

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

NCT04602533 2026-02-27

Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)

Phase 2 Active not recruiting

Lung Neoplasms

NCT05564468 2026-02-27

Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer

Phase NA Completed

Neoplasm Metastasis

NCT05574673 2026-02-27

HERO

Kenny-Caffey syndrome, Type 1, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06945380 2026-02-27

Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

Phase NA Recruiting

OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

NCT07022678 2026-02-27

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07318389 2026-02-27

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07434817 2026-02-27

Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment

Phase NA Not yet recruiting

Breast Cancer Females

NCT07436663 2026-02-27

SGLT2i/DPPi

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07438860 2026-02-27

Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG

Phase 1 Not yet recruiting

Glioma

NCT06484595 2026-02-25

GUIDE

Phase NA Completed

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06585410 2026-02-25

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Phase 3 Recruiting

Skin Neoplasms

NCT03997162 2026-02-24

Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery

Active not recruiting

Gastrointestinal

Clinical Stage 0 Gastric Cancer AJCC v8

NCT06513962 2026-02-24

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Phase 3 Recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06855277 2026-02-24

AcTFirst

Phase 3 Recruiting

Prostatic Neoplasms

NCT06037863 2026-02-23

Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial

Phase NA Active not recruiting

Prostatic Neoplasms

NCT07025538 2026-02-23

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Phase 1 Suspended

Hematopoietic and Lymphatic System Neoplasm

NCT04876651 2026-02-20

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Phase 3 Terminated

Prostatic Neoplasms

NCT07184047 2026-02-20

TOX-FRAIL

Gastrointestinal

Frailty, Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Malnutrition, Sarcopenia, Sarcoglycanopathies